Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases

Deviprasad R Gollapalli1, Iain S Macpherson, George Liechti

  • 1Department of Biology, Brandeis University, 415 South Street, Waltham, MA 02454-9110, USA.

Chemistry & Biology
|November 2, 2010
PubMed

Insights

New drug candidates targeting Cryptosporidium parvum inosine monophosphate dehydrogenase (CpIMPDH) show promise as novel antibiotics. These inhibitors are effective against various bacterial IMPDHs, sparing beneficial gut bacteria.

Area of Science:

  • Parasitology
  • Microbiology
  • Drug Discovery

Background:

  • Cryptosporidium parvum causes significant gastrointestinal illness with no effective treatments.
  • CpIMPDH exhibits close homology to prokaryotic IMPDHs, suggesting horizontal gene transfer.
  • Existing CpIMPDH inhibitors do not affect human IMPDH, indicating target specificity.

Purpose of the Study:

  • To investigate the potential of CpIMPDH inhibitors as broad-spectrum antibacterial agents.
  • To identify structural features of IMPDH enzymes conferring susceptibility to inhibitors.
  • To evaluate the therapeutic potential of second-generation inhibitors against specific bacterial pathogens.

Main Methods:

  • Enzyme inhibition assays using CpIMPDH and IMPDH from various bacterial species (H. pylori, B. burgdorferi, S. pyogenes, E. coli).
  • Structural analysis to identify key residues (Ala165, Tyr358) in susceptible IMPDH enzymes.
  • Bactericidal activity assays of a second-generation CpIMPDH inhibitor against H. pylori and E. coli.

Main Results:

  • CpIMPDH inhibitors demonstrated activity against IMPDH from H. pylori, B. burgdorferi, and S. pyogenes, but not E. coli.
  • A conserved structural motif (Ala165, Tyr358) was identified as critical for enzyme susceptibility.
  • A second-generation inhibitor exhibited bactericidal effects on H. pylori without harming E. coli.

Conclusions:

  • CpIMPDH-targeted inhibitors represent a promising new class of antibiotics.
  • These compounds show selective activity against pathogenic bacteria, potentially sparing commensal flora.
  • Further development could lead to novel therapeutic strategies for parasitic and bacterial infections.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...